Abstract
As people age, maintaining mobility becomes increasingly imperative, therefore addressing bone health is the most important way to preserve mobility. Poor bone health encompasses a broad spectrum of diseases, but it is most often quantified as the cumulative burden of osteoporosis and osteoporotic fractures. Rates of these fractures have been increasing and are expected to continue rising globally, attributed to increasing life expectancy worldwide. No single strategy will be sufficient to address this global public health issue. Co-ordination across a wide array of stakeholders is vital to decrease the health and socioeconomic burden of poor bone health. Stakeholders include an assortment of specialists ranging from health professionals (primary and secondary care clinicians, nurses, physical therapists, and social care workers), policy-makers, government bodies (including departments of health and social services), employers, civil society, as well as patients and their caregivers. We need to ensure that there is a better understanding of the socioeconomic and health consequences of poor bone health to promote better policies to address needs. Building a more resilient health system approach to bone health based on the evidence and sound decision-making will not only improve population health, but will provide cost savings to health systems by preventing poor bone health in the first place. Health systems around the world must prioritise bone health to preserve mobility and wellbeing in advance of the impending surge in demand from ageing populations. Poor bone health is not an inevitable part of ageing. Working across the lifespan, we can all benefit from improved bone health throughout our lives.
Similar content being viewed by others
Availability of data and material
References provided.
References
WHO (2021) UN Decade of Healthy Ageing: World Health Organization. https://www.who.int/initiatives/decade-of-healthy-ageing#:~:text=The%20United%20Nations%20Decade%20of,improve%20the%20lives%20of%20older. Accessed on 10 Nov 2020
Kanis JA, Cooper C, Rizzoli R, Scientific Advisory Board of the European Society for C Economic Aspects of O et al (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3–44
Borgström F, Karlsson L, Ortsäter G et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15:59. https://doi.org/10.1007/s11657-020-0706-y
Katsoulis M, Benetou V, Karapetyan T et al (2017) Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project. J Intern Med 281:300–310
Gosch M, Druml T, Nicholas J et al (2015) Fragility non-hip fracture patients are at risk. Arch Orthop Trauma Surg 135:69–77
Javaid MK, Kyer C, Mitchell PJ et al (2015) Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture R Best Practice Framework tool. Osteoporos Int 26:2573–2578
Compston JE, McClung MR, Leslie WD (2019) Osteoporosis. The Lancet. https://doi.org/10.1016/S0140-6736(18)32112-3
McCloskey E, Rathi J, Heijmans S et al (2021) The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study. Osteoporos Int 32:251–259. https://doi.org/10.1007/s00198-020-05557-z
Strom O, Borgstrom F, Kanis JA et al (2011) Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6:59–155
Harvey NC, McCloskey EV, Mitchell PJ et al (2017) Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int 28:1507–1529
Li N, Cornelissen D, Silverman S et al (2020) An updated systematic review of cost-effectiveness analyses of drugs for osteoporosis. Pharmacoeconomics. https://doi.org/10.1007/s40273-020-00965-9
Vijayakumar R (2016) Busselberg D (2016) Osteoporosis: An under-recognized public health problem Local and global risk factors and its regional and worldwide prevalence. J Local Global Health Sci 1:1–13. https://doi.org/10.5339/jlghs.2016.2
Barnsley J, Buckland G, Chan PE et al (2021) Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging Clin Exp Res 33:759–773. https://doi.org/10.1007/s40520-021-01817-y
IOF (2020) Epidemiology of osteoporosis and fragility fractures. Nyon: International Osteoporosis Foundation; undated International Osteoporsis Foundation. https://www.osteoporosis.foundation/facts-statistics/epidemiology-of-osteoporosis-and-fragility-fractures. Accessed on 10 Nov 2020
Kaufman J-M (2021) Management of osteoporosis in older men. Aging Clin Exp Res 33:1439–1452. https://doi.org/10.1007/s40520-021-01845-8
UN (2017) World population prospects: the 2017 revision. New York, NY: United Nations. https://www.un.org/development/desa/publications/world-population-prospects-the-2017-revision.html. Accessed on 10 Nov 2020
Kanis JA, Johansson H, Harvey N et al (2020) Adjusting conventional FRAX estimates of fracture probability according to the recency of sentinel fractures. Osteoporos Int 31:1817–1828
IOF (2019) Bone facts: National Osteoporosis Foundation Bone Health Policy Institute. https://www.bonehealthpolicyinstitute.org/bone-facts. Accessed on 10 Nov 2020
Thayer SW, Stolshek BS, Gomez Rey G et al (2014) Impact of osteoporosis on high-cost chronic diseases. Value Health 17:43–50
Roux C, Briot K (2020) The crisis of inadequate treatment in osteoporosis. The Lancet Rheumatol. https://doi.org/10.1007/s00198-017-3976-5
Cornelissen D, de Kunder S, Si L et al (2020) Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int. https://doi.org/10.1007/s00198-020-05378-0
Cutler RL, Fernandez-Llimos F, Frommer M et al (2018) Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. https://doi.org/10.1136/bmjopen-2017-016982
Eurostat (2017) People in the EU: Statistics on demographic changes. Brussels: European Commission. https://ec.europa.eu/eurostat/statisticsexplained/index.php?title=Archive:People_in_the_EU_-_statistics_on_demographic_changes&oldid=458857#:~:text=There%20were%20511.8%20million%20inhabitants,20%20%25%20from%20natural%20population%20change. Accessed on 23 Oct 2020
Eurostat (2017) Dataset: Demographic challenges - population projections tables and figures. Brussels: European Commission. https://ec.europa.eu/eurostat/statistics-xplained/index.php/Archive:Population_projections. Accessed on 23 Oct 2020
UN (2019World population prospects 2019. New York: United Nations department of economic and social affairs; 2019. Available from: https://population.un.org/wpp/. Accessed 5 Jan 2021
Taylor P (2019) Working longer may be good public policy, but it is not necessarily good for older people. J Aging Social Policy 31:99–105
Crawford JO, Graveling RA, Cowie H, Dixon K (2010) The health safety and health promotion needs of older workers. Occup Med 60:184–192
IOF (2018) Broken bones, broken lives – the fragility fracture crisis in six European countries. International Osteoporosis Foundation. https://share.iofbonehealth.org/EU-6-Material/Reports/IOF%20Report_EU.pdf. Accessed on 14 Nov 2020
Council NR (2010) Informal caregivers in the United States: prevalence, caregiver characteristics, and ability to provide care. The role of human factors in home health care: Workshop summary. National Academies Press (US). Washington [DC]: The National Academies Press 117-143
Bentler SE, Liu L, Obrizan M et al (2009) The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol 170:1290–1299
Png M, Griffin X, Costa M et al (2020) Utilization and costs of formal and informal care, home adaptations, and physiotherapy among older patients with hip fracture. Bone Joint Res 9:250–257
Seaman AT, Steffen M, Doo T et al (2018) Metasynthesis of patient attitudes toward bone densitometry. J Gen Internal Med 33:1796–1804
Eastell R, Rosen CJ, Black DM et al (2019) Pharmacological management of osteoporosis in postmenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 104:1595–1622
UCF.RC. (2019-2020) Osteoporosis, risk of fractures and falls. Coimbra: Unidade Coordenadora Funcional em Reumatologia do Centro
Roux C, Briot K (2017) Imminent fracture risk. Osteoporos Int 28:1765–1769
Kanis JA, Johansson H, Odén A et al (2018) Characteristics of recurrent fractures. Osteoporos Int 29:1747–1757
IOF (2021) Capture the fracture International Osteoporosis Foundation. https://www.capturethefracture.org/. Accessed 4 July 2021
Javaid MK (2021) Efficacy and efficiency of fracture liaison services to reduce the risk of recurrent osteoporotic fractures. Aging Clin Exp Res. https://doi.org/10.1007/s40520-021-01844-9
Reginster J, Cooper C, Kanis J et al (2017) CAPTURE THE FRACTURE: INTEGRATED CARE PREVENTS THE DECREASE IN INTRINSIC CAPACITY IN ELDERLY SUBJECTS. Innov Aging. https://doi.org/10.1093/geroni/igx004.2478
Pioli G, Bendini C, Pignedoli P et al (2018) Orthogeriatric co-management—managing frailty as well as fragility. Injury 49:1398–1402
Mitchell PJ, Cooper C, Fujita M et al (2019) Quality improvement initiatives in fragility fracture care and prevention. Current Osteoporos Rep 17:510–520
Hagino H, Wada T (2019) Osteoporosis liaison service in Japan. Osteoporos Sarcopenia 5:65–68
Nationellt System för Kunskapsstyrning Hälso - och Sjukvård (2020) Patient-centred and cohesive osteoporosis care pathway-secondary prevention after fracture. Sveriges Regioner i samverkan. Available from https://kunskapsstyrningvard.se/. Accessed 20 Jan 2021
FFN (2021) What we do Zurich Fragility Fracture Network. https://www.fragilityfracturenetwork.org/. Accessed on 2 Nov 2020
Javaid MK, Sami A, Lems W, Mitchell P, Thomas T, Singer A et al (2020) A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network. Osteoporos Int 31:1193–1204
Shipman KE, Doyle A, Arden H, Jones T, Gittoes NJ (2017) Development of fracture liaison services: What have we learned? Injury 48:S4–S9
Toro N (2015) Who global strategy on integrated people-centred health services (IPCHS)/Estrategia mundial en servicios de salud integrada centrado en las personas (IPCHS). International Journal of Integrated Care 15(8)
WHO (2020) Framework on integrated people-centred health services Geneva: World Health Organization. https://www.who.int/servicedeliverysafety/areas/people-centred-care/framework/en/. Accessed on 10 Nov 2020
Hosking S, Buchbinder R, Pasco J, Williams L, Brennan-Olsen S (2016) The role of health literacy in the treatment of osteoporosis. J Bone Miner Res 31:1909
WHO (2017) 10 priorities towards a decade of healthy ageing. World Health Organization. https://www.who.int/ageing/WHO-ALC-10-priorities.pdf?ua=1. Accessed on 10 Nov 2020
Apple (2021) Press release. https://www.apple.com/uk/newsroom/2021/06/apple-advances-personal-health-by-introducing-secure-sharing-and-new-insights/. Accessed on 6 July 2021
El Miedany Y (2021) Recent developments towards closing the gap in osteoporosis management. Egypt Rheumatol Rehabil 48:4. https://doi.org/10.1186/s43166-020-00048-9
Acknowledgements
We are indebted to our Expert Panel for their contributions, insights and time they generously shared with us. The Expert Panel members were: Professor Robert Blank, Professor Emeritus of Medicine, Medical College of Wisconsin; Visiting Scientist, Garvan Institute of Medical Research, Australia; Professor Cyrus Cooper, OBE, Professor of Rheumatology and Director of the MRC Life Course Epidemiology Unit, Vice-Dean of the Faculty of Medicine at the University of Southampton, Professor of Epidemiology at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK; Professor Michael Graven, Retired faculty from Dalhousie University, Former Director, Medical Informatics, USA; Dr Samuel Hailu, Orthopaedic Trauma and Arthroplasty Surgeon, Addis Ababa University, Tikur Anbessa (Black Lion) Specialized Hospital, Ethiopia; Dr Phillippe Halbout, Chief Executive Officer, International Osteoporosis Foundation, Switzerland; Ms Teréza Hough, Chief Executive Officer, National Osteoporosis Foundation of South Africa; Dr Andréa Marques, Rheumatology Department, Centro Hospitalar e Universitario de Coimbra; Nursing, Health Sciences Research Unit, Portugal; Professor Eugene McCloskey, Professor, Adult Bone Diseases, Director of the MRC Versus Arthritis Centre for Integrated Research in Musculoskeletal Ageing, Healthy Lifespan Institute, Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, University of Sheffield, UK; Professor Rosa Maria Pereira, Department of Rheumatology, Hospital das Clinicas HCFMUSP, Professor at the Faculty of Medicine of the University of Sao Paulo, Brazil; Ms Lisa Qualls, Director of Partner Relations, American Bone Health, USA; Professor Jean-Yves Reginster, MD, PhD, University of Liege, Belgium, King Saud University; Dr Kanwaljit Soin, Orthopaedic and Hand Surgeon, Former Nominated Member of Parliament of Singapore, Founding President of Women’s Initiative for Ageing Successfully, Author of ‘Silver Shades of Grey: Memos for Successful Ageing In the 21st Century’, Singapore; Dr Maria Belen Zanchetta, Medical and Academic Director, IDIM, Director, Postgraduation Chair in Osteology and Mineral Metabolism at Salvador’s University, Member, ASBMR Membership Engagement Committee; Ambassador, LATAM ASBMR, Regional Advisory Committee, International Osteoporosis Foundation, Argentina. We are grateful for the input we received from the specialists we interviewed: Dr Gemma Adib, Founder and President, Syrian National Osteoporosis Society, Board member, International Osteoporosis Foundation Regional, Advisory Committee Chair, RAC; Pan Arab Osteoporosis Society GS (PAOS); Professor Paul Anderson, Professor, Department of Orthopedics Surgery and Rehabilitation, University of Wisconsin; Dr Bruno Boietti, Medical Professional, Hospital Italiano of Buenos Aires, Consultant, Ministry of Health, Argentina; Professor Matthew Costa, Professor of Orthopaedic Trauma, University of Oxford, Honorary Consultant Trauma Surgeon, John Radcliffe Hospital; Professor Juliet Compston, Professor Emeritus of Bone Medicine, Cambridge Biomedical Campus; Dr Greg Lyubomirsky, CEO, Osteoporosis Australia; Dr Jay Magaziner, Chair, Department of Epidemiology and Public Health, Director, Center For Research on Aging, University of Maryland; Dr Polyzois Makras, Consultant Endocrinologist, Department of Endocrinology and Diabetes, Head of the Department of Medical Research, 251 Hellenic Air Force and VA General Hospital; Dr Paul Mitchell, Founder, Synthesis Medical Limited; Professor Sonia Cerdas Pérez, Professor of Endocrinology, University of Costa Rica, Endocrinologist, Hospital CIMA, Founder, Costa Rican Menopause and Osteoporosis Society; Professor Leith Zakraoui, Professor of Rheumatology, University of Tunis School of Medicine, Head of the Department of Rheumatology, Hospital Mongi Slim La Marsa, Founder, Tunisian Osteoporosis Prevention Society (TOPS). We extend a special thanks to our expert consultant, Professor Liesbeth Borgermans, Professor of Primary Care, Faculty of Medicine and Health Sciences, Department of Public Health and Primary Care, University of Ghent, Belgium, for her guidance and views.
Funding
The research was sponsored by Amgen.
Author information
Authors and Affiliations
Contributions
This research was conducted by The Economist Intelligence Unit Health Policy team from 2020 to 2021. The Economist Intelligence Unit bears sole responsibility for the content of this report. The findings and views expressed in the report do not necessarily reflect the views of the sponsor. The research was led by Dr Mary Bussell with input from The Economist Intelligence Unit team consisting of Taylor Puhl, Amanda Stucke, Marcela Casaca, Giulia Garcia, Lorena Perez and Janet Clapton.
Corresponding author
Ethics declarations
Conflict of interest
The author has no conflict of interest or competing interests.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study formal consent is not required.
Consent for publication
I, Mary Bussell, consent for this manuscript to be published.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bussell, M.E. Improving bone health: addressing the burden through an integrated approach. Aging Clin Exp Res 33, 2777–2786 (2021). https://doi.org/10.1007/s40520-021-01971-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-021-01971-3